Monitoring serum estradiol levels in breast cancer patients during extended adjuvant letrozole treatment after five years of tamoxifen: a prospective trial-Reference-Cited by-同舟云学术

Monitoring serum estradiol levels in breast cancer patients during extended adjuvant letrozole treatment after five years of tamoxifen: a prospective trial

Published:2021-03-12 Issue:3 Volume:187 Page:769-775
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Faltinová Mária^ORCID,Vehmanen Leena,Lyytinen Heli,Haanpää Mikko,Hämäläinen Esa,Tiitinen Aila,Blomqvist Carl,Mattson Johanna

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-021-06168-w.pdf

Reference17 articles.

1. Breast International Group, Thurlimann B, Keshaviah A et al (2005) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353:2747–2757

2. Santen RJ, Samojlik E, Wells SA (1980) Resistance of the ovary to blockade of aromatization with aminoglutethimide. J Clin Endocrinol Metab 51:473–477

3. Davies C, Pan H, Godwin J et al (2013) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381:805–816

4. Goss PE (2007) Letrozole in the extended adjuvant setting: MA.17. Breast Cancer Res Treat 105(Suppl 1):45–53

5. Rosendahl M, Ahlgren J, Andersen J et al (2009) The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000–1 study. Eur J Cancer 45:3198–3204

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of multiple steroid hormones in serum and human breast cancer tissue by liquid chromatography-tandem mass spectrometry analysis;Frontiers in Oncology;2024-05-28

2. Effectiveness of gonadotropin-releasing hormone agonists for ovarian function suppression in premenopausal patients with hormone receptor-positive breast cancer: a retrospective single-center real-world study;Breast Cancer Research and Treatment;2024-05-06

3. Design and Validation of a Short Novel Estradiol Aptamer and Exploration of Its Application in Sensor Technology;Molecules;2024-01-22

4. Effects of letrozole on serum estradiol and estrone in postmenopausal breast cancer patients and tolerability of treatment: a prospective trial using a highly sensitive LC–MS/MS (liquid chromatography–tandem mass spectrometry) method for estrogen measurement;Breast Cancer Research and Treatment;2023-07-25

5. Association of serum cortisol and cortisone levels and risk of recurrence after endocrine treatment in breast cancer;Clinical and Experimental Medicine;2023-07-03